Panitumumab (powder)

Panitumumab (ABX-EGF) (powder) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (powder) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (powder) can be used in the research of cancers, such as colon cancer[1].

Product Specifications

CAS Number

[339177-26-3]

Product Name Alternative

ABX-EGF (powder)

UNSPSC

12352203

Target

EGFR

Related Pathways

JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Smiles

[Panitumumab(powder)]

Molecular Weight

(144.32 kDa)

References & Citations

[1]Liu SH, et al. EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR. Int J Mol Med. 2019 Jul;44 (1) :79-88.